Sami Alnasser

Interventional Cardiologist | St Michael’s Hospital @UnityhealthTo | University of Toronto @UofT | Transcatheter Structural and Congenital Heart Interventions.

[Sami Alnasser @SamiAlnasserMD]

@iNoraalnasser هلا والله ابشرك بخير

[Sami Alnasser @SamiAlnasserMD]

#AlHilal

[Sami Alnasser @SamiAlnasserMD]

https://t.co/O6VD1PZw2B

[Sami Alnasser @SamiAlnasserMD]

Optimal management of CIED leads pre- TTVR is an area of evolving knowledge. In our recent analysis @JACCJournals, the presence of transvalvular leads was associated with recurrent TR following initially successful TTVR with a non-leaflet-capture platform. @npfam1

[EuroIntervention @EuroInterventio]

First-in-human experience with the Unica cross-caval device for severe tricuspid regurgitation.

Among 8 high-risk patients, implantation was associated with high procedural success, haemodynamic improvement and encouraging early clinical outcomes.

🔗https://t.co/FwVbj2cTWV

#TTVR #TricuspidValve #CardioTwitter
@manuelbarreirop @freixa_xavier @j_hausleiter @SamiAlnasserMD @npfam1

[Sanjay Kaul @kaulcsmc]

https://t.co/ixNPIJJha7

1/
CHIP-BCIS3: Another Impella Trial bites the dust

History of Impella device:

2008: approved despite pivotal trial PROTECT II (n=448) stopped for futility

2015: Label extended for improving hemodynamic support during high-risk PCI

[Sami Alnasser @SamiAlnasserMD]

Agree , morphology-based recommendations should be considered in future guidelines !

[Prasham Dave @Prasham_D]

Excited to share our latest AJC publication on PBMV in patients with left atrial thrombus. It is a contemporary look at safety and outcomes in a traditionally high-risk cohort.
@SamiAlnasserMD @MelissaMoeyMD @npfam1 @UnityHealthTO

https://t.co/sVQpKGlqUn

[Andrea Scotti @AndreaScotti21]

⚠️ Are we underestimating paravalvular leak after TTVR?

In TRIPLACE, ≥Mod PVL occurred in 6.1% and was associated w/
🔴39.7% 1-year mortality
🔴2.6X higher risk of death
🔴Less symptomatic improvement despite successful TTVR

🔗https://t.co/gVLck1eND1

@azeemlatib Rishi Puri

[Abdulaziz Al-Shaibi @AbdulazizShaibi]

Always a great time at Toronto Valves!
Join us again next year to see the latest in transcatheter and surgical valve interventions.

@npfam1 @SamiAlnasserMD @jamiemccabeMD @GBisleri @DJPBurns @EdwinHoMD

[Andrea Scotti @AndreaScotti21]

TTVR + CIED leads: What really happens?
Insights from the TRIPLACE Registry in #JACCEP

🎯 Same procedural success
⚠️ Lead failure 5.8%
🫀 More ≥moderate PVL
✅ 30-day mortality not increased

Free (50 days): https://t.co/Uzq2ztjlAE

@MontefioreNYC @EinsteinMed @JACCJournals

[Sami Alnasser @SamiAlnasserMD]

@mirvatalasnag @HatimLawati @AliSahebHusain @dr_aalenezi @AlhijjiM @SCAI @PCRonline @npfam1 Thanks Mirvat!
Great result, Hatem! The issue can be longevity, good thing that it can be repeated in case of recurrence, if not a candidate for more definitive therapy

[EuroIntervention @EuroInterventio]

Transjugular implantation of the Topaz TTVR successfully treats severe TR with challenging IVC–annulus anatomy — expanding options for complex tricuspid cases. https://t.co/AgVurUsk3X #TTVR #EuroIntervention #StructuralHeart #cardiotwitter
@AmrGama00480068
@SamiAlnasserMD
@npfam1

[Mohammed Shurrab MD MSc PhD @MoShurrabMD]

My friend and colleague ⁦@SamiAlnasserMD⁩ presenting today in Sudbury at the Cardiovascular Symposium- An amazing talk!! ⁦@HSN_Sudbury⁩⁩ ⁦@HSNRI⁩ ⁦@UnityHealthTO⁩ ⁦@thenosm⁩

[Sami Alnasser @SamiAlnasserMD]

@MoShurrabMD @HSN_Sudbury @HSNRI @UnityHealthTO @thenosm Pleasure and honour @MoShurrabMD

[Sami Alnasser @SamiAlnasserMD]

Very interesting.! Congrats @MoShurrabMD

[Sandeep Gautam @gautamsand]

📢New Meta-analysis: Rate vs Rhythm Control in AF and Risk of Syncope, Falls & Pacing @hrs_journal @HRSonline @MoShurrabMD
#EPeeps #CardioTwitter
*⃣Background
While early rhythm control m.b. beneficial (EAST-AFNET 4; CASTLE-AF, EARLY-AF), rhythm therapy—especially with AADs—may increase bradycardia-related complications.
*⃣ Why?
⭐️Sinus node dysfunction
⭐️ AAD induced SAN/ AVN pathology

https://t.co/QRsDbRSaRT

[Sami Alnasser @SamiAlnasserMD]

@BryanTraynor6 @npfam1 @docjohnnyg @abagaimd Great work Bryan , congratulations!

[Sami Alnasser @SamiAlnasserMD]

@DrMsk1988 @npfam1 @abagaimd Congratulations Mo !

[Sami Alnasser @SamiAlnasserMD]

Great work @BryanTraynor6 !

[Bryan Traynor @BryanTraynor6]

Multiple ASDs can require multiple closure devices. We demonstrate the “interleaving” and “sandwiching” methods using the Gore Cardioform ASD Occluder and their advantages in these different anatomies. #JACCINT @JACCJournals @SamiAlnasserMD @npfam1 https://t.co/ku9OcoTJGk

[Sami Alnasser @SamiAlnasserMD]

https://t.co/KwfMNXtEXe

[Sami Alnasser @SamiAlnasserMD]

TV anatomy and TR mechanisms are highly variable, highlighting the need for continued innovation to expand Rx options. After the FDA approval of EDWARDS EVOQUE, it’s exciting to see more TTVR THV options on the horizon ! @JACCJournals @npfam1

https://t.co/okENSj6R7d